Zobrazeno 1 - 10
of 384
pro vyhledávání: '"Oloke JK"'
Autor:
Oladipo EK; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Laboratory of Molecular Biology, Immunology and Bioinformatics, Department of Microbiology, Adeleke University, Ede, Osun State, Nigeria., Oyelakin OD; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Aiyelabegan AO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Olajide EO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Molecular Biology and Biotechnology Department, Nigeria Institute of Medical Research, Lagos, Nigeria., Olatayo VO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Owolabi KP; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Shittu YB; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Olugbodi RO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Ajala HA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Rukayat RA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Olayiwola DO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Irewolede BA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Jimah EM; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Oloke JK; Department of Natural Sciences, Precious Cornerstone University, Ibadan, Oyo State, Nigeria., Ojo TO; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria., Ajani OF; African Centre for Disease Control HQ, Addis Ababa, Ethiopia., Iwalokun BA; Molecular Biology and Biotechnology Department, Nigeria Institute of Medical Research, Lagos, Nigeria., Kolawole OM; Department of Microbiology, University of Ilorin, Ilorin, Kwara State, Nigeria., Ariyo OE; Department of Medicine, Infectious Disease and Tropical Medicine Unit, Federal Teaching Hospital, Ido Ekiti, Ekiti State, Nigeria., Adediran DA; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria., Olufemi SE; Division of Vaccine Design and Development, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria., Onyeaka H; School of Chemical Engineering, University of Birmingham, Birmingham, UK.
Publikováno v:
Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Aug; Vol. 12 (8), pp. e1360.
Autor:
Oladipo EK; Laboratory of Molecular Biology, Immunology and Bioinformatics, Department of Microbiology, Adeleke University, Ede, Osun State Nigeria.; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Akinleye TM; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria.; Department of Anatomy and Advanced Research Center for Tumor Immunology, Inje University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan, 47392 Republic of Korea., Adeyemo SF; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Akinboade MW; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Siyanbola KF; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Adetunji VA; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Arowosegbe OA; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Olatunji VK; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Adaramola EO; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Afolabi HO; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Ajani CD; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Siyanbola TP; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Folakanmi EO; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Irewolede BA; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Okesanya OJ; Faculty of Medicine, Department of Public Health and Maritime Transport, Laboratory of Hygiene and Epidemiology, University of Thessaly, Papakyriazi 22, Larissa, 41222 Greece., Ajani OF; African Centre for Disease Control and Prevention (African CDC), Addis Ababa, Ethiopia., Ariyo OE; Department of Medicine, Infectious Diseases and Tropical Medicine Unit, Federal Teaching Hospital, Ido-Ekiti, Ekiti State Nigeria., Jimah EM; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo State Nigeria., Iwalokun BA; Molecular Biology and Biotechnology Department, Nigerian Institute of Medical Research, Lagos, Nigeria., Kolawole OM; Department of Microbiology, University of Ilorin, Ilorin, 234031 Nigeria., Oloke JK; Department of Natural Science, Precious Cornerstone, Ibadan, 200132 Nigeria., Onyeaka H; School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B15 2TT UK.
Publikováno v:
In silico pharmacology [In Silico Pharmacol] 2024 Jul 24; Vol. 12 (2), pp. 68. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).
Autor:
Taiwo OR; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo, Nigeria., Onyeaka H; School of Chemical Engineering, University of Birmingham, Edgbaston B15 2TT, Birmingham, UK., Oladipo EK; Genomics Unit, Helix Biogen Institute, Ogbomosho, Oyo, Nigeria.; Department of Microbiology, Laboratory of Molecular Biology, Immunology and Bioinformatics, Adeleke University, Ede, Osun, Nigeria., Oloke JK; Department of Natural Science, Microbiology Unit, Precious Cornerstone University, Ibadan, Oyo, Nigeria., Chukwugozie DC; Department of Microbiology, Federal University Otuoke, Otuoke, Bayelsa, Nigeria.
Publikováno v:
International journal of microbiology [Int J Microbiol] 2024 May 17; Vol. 2024, pp. 6612162. Date of Electronic Publication: 2024 May 17 (Print Publication: 2024).
Autor:
Bamigboye CO; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria. coadegunlola@lautech.edu.ng., Akinola OE; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Adegboye JD; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Fadiora IA; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Omomowo IO; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Majolagbe ON; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Oyeleke OR; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Alarape AA; Department of Animal Production and Health, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Ojediran TK; Department of Animal Production and Health, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Shittu MD; Department of Animal Production and Health, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria., Oloke JK; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.
Publikováno v:
Tropical animal health and production [Trop Anim Health Prod] 2024 Apr 22; Vol. 56 (4), pp. 136. Date of Electronic Publication: 2024 Apr 22.
Autor:
Oladipo EK; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo, Nigeria.; Laboratory of Molecular Biology, Immunology and Bioinformatics, Adeleke University, Ede, Osun State, Nigeria., Olufemi SE; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria., Adediran DA; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria., Adejumo IO; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo, Nigeria., Jimah EM; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo, Nigeria., Oloke JK; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo, Nigeria.; Department of Natural Sciences, Precious Cornerstone University, Ibadan, Nigeria., Udekwu CC; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, United States., Ogunwobi OO; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Feb 21; Vol. 14, pp. 1325614. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Autor:
Ajibade OA; Department of Microbiology, Laboratory of Industrial Microbiology, Adeleke University, Ede, Osun State, Nigeria; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria. Electronic address: oluwatosin.ajibade@gmail.com., Oladipo EK; Department of Microbiology, Laboratory of Industrial Microbiology, Adeleke University, Ede, Osun State, Nigeria; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria. Electronic address: koladipo2k3@yahoo.co.uk., Kwenda S; Sequencing Core Facility, National Institute for Communicable Diseases, National Health Laboratory Service, 1 Modderfontein Road, Sandringham, Johannesburg, Gauteng, South Africa., Khumalo Z; Sequencing Core Facility, National Institute for Communicable Diseases, National Health Laboratory Service, 1 Modderfontein Road, Sandringham, Johannesburg, Gauteng, South Africa; Veterinary Tropical Diseases Department, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa., Ismail A; Sequencing Core Facility, National Institute for Communicable Diseases, National Health Laboratory Service, 1 Modderfontein Road, Sandringham, Johannesburg, Gauteng, South Africa., Oloke JK; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria; Precious Cornerstone University, Off Old Ife Road, Agodi, Ibadan, Oyo State, Nigeria. Electronic address: jkoloke@yahoo.co.uk., Oyawoye OM; Department of Microbiology, Laboratory of Industrial Microbiology, Adeleke University, Ede, Osun State, Nigeria; Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo State, Nigeria. Electronic address: oyawoyeom@gmail.com., Onyeaka H; School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: h.onyeaka@bham.ac.uk.
Publikováno v:
Gene [Gene] 2023 Dec 15; Vol. 887, pp. 147725. Date of Electronic Publication: 2023 Aug 23.
Autor:
Oladipo EK; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Laboratory of Molecular Biology, Immunology and Bioinformatics, Department of Microbiology, Adeleke University, Ede 231104, Nigeria., Adeniyi MO; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria., Ogunlowo MT; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria., Irewolede BA; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria., Adekanola VO; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Department of Pure and Applied Biology, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Oluseyi GS; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Department of Human and Clinical Anatomy, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Omilola JA; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Department of Pure and Applied Biology, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Udoh AF; Department of Biochemistry, Obafemi Awolowo University, Ile-Ife 220005, Nigeria., Olufemi SE; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Adediran DA; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Olonade A; Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Idowu UA; Genomics Unit, Helix Biogen Institute, Ogbomoso 210214, Nigeria.; Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, Ogbomoso 210214, Nigeria., Kolawole OM; Department of Microbiology, University of Ilorin, Ilorin 234031, Nigeria., Oloke JK; Department of Natural Science, Precious Cornerstone, Ibadan 200132, Nigeria., Onyeaka H; School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Dec 09; Vol. 10 (12). Date of Electronic Publication: 2022 Dec 09.
Autor:
Baeka GB; Department of Pure and Applied Biology (Microbiology/Virology Unit), Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.; Department of Microbiology, Rivers State University, Port Harcourt, Rivers State., Oloke JK; Department of Pure and Applied Biology (Microbiology/Virology Unit), Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria., Opaleye OO; Department of Pure and Applied Biology (Microbiology/Virology Unit), Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.; Department of Medical Microbiology and Parasitology, College of Health Sciences, Ladoke Akintola University of Technology, Nigeria.
Publikováno v:
African health sciences [Afr Health Sci] 2021 Sep; Vol. 21 (3), pp. 1010-1015.
Publikováno v:
International Journal of Medicine and Biomedical Research; Vol 4, No 3 (2015); 135-141
Background: The emergence of beta-lactam resistance in Pseudomonas aeruginosa is a major global challenge, particularly, the rise in the resistance to 3rd and 4th generation cephalosporins.Aim: This study was carried out to determine the resistance p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::b789932a9880b579cc5a7540ed835f3a
https://www.ajol.info/index.php/ijmbr/article/view/129147
https://www.ajol.info/index.php/ijmbr/article/view/129147
Autor:
Oladipo, Elijah Kolawole1,2,3,4 (AUTHOR) koladipo2k3@yahoo.co.uk, Ogunniran, James Akinwumi2 (AUTHOR), Akinpelu, Oluwaseyi Samuel2 (AUTHOR), Omole, Tosin Omoboyede2 (AUTHOR), Adeyemo, Stephen Feranmi1 (AUTHOR), Irewolede, Boluwatife Ayobami1 (AUTHOR), Iwalokun, Bamidele Abiodun5 (AUTHOR), Ajani, Olumide Faith6 (AUTHOR), Onyeaka, Helen4 (AUTHOR) h.onyeaka@bham.ac.uk
Publikováno v:
BMC Immunology. 11/20/2024, Vol. 25 Issue 1, p1-13. 13p.